Renal Denervation for Hypertension　- Mechanisms, Evidence, and Clinical Integration

Area of Science:

• Cardiovascular medicine
• Interventional cardiology
• Nephrology

Background:

• Renal sympathetic nerve activity contributes to hypertension.
• Catheter-based renal denervation offers a minimally invasive approach to modulate this activity.
• Understanding its long-term effects and integration with pharmacotherapy is crucial.

Purpose of the Study:

• To review the mechanism, anatomy, and clinical trial evidence for renal denervation.
• To summarize long-term outcomes regarding blood pressure control, renal function, and safety.
• To discuss practical considerations for incorporating renal denervation into hypertension management.

Main Methods:

• Review of placebo-controlled trials and long-term follow-up data from randomized programs and registries.
• Analysis of data on ambulatory and office blood pressure, renal function, and re-intervention rates.
• Synthesis of information on the mechanism and target anatomy of renal denervation.

Main Results:

• Renal denervation significantly reduces both ambulatory and office blood pressure compared to placebo.
• The blood pressure-lowering effect is sustained over several years, with some data approaching a decade.
• The procedure demonstrates a favorable safety profile with preserved renal function and low re-intervention rates.

Conclusions:

• Renal denervation is an effective therapy for lowering blood pressure through durable neuromodulation.
• Long-term data support sustained efficacy and safety, making it a viable option for uncontrolled hypertension.
• Integration with pharmacologic therapy is a key consideration for optimizing patient outcomes.